Search
SOLACI Congress
HomeStructural heart diseaseValvular Aortic Valve

Valvular Aortic Valve

View Category
Highlighted Presentations

SOLACI-SBHCI 2023 | TAVR – Lifetime Management of Patients with Aortic Stenosis – Dr. Ole de Backer

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr....
solaci -
Learn More
Structural heart disease

Moderate Aortic Stenosis: We Should Start Assessing It More Thoroughly

Moderate aortic stenosis (MAS) encompasses a broader spectrum than severe aortic stenosis. However, its progression has not...
solaci -
Learn More
Highlighted Presentations

SOLACI-SBHCI 2023 | Mitral Valve Interventions beyond the TEER Era: Time to Re-Evaluate Innovation Priorities?- Dr. Eberhard Grube

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. Eberhard...
solaci -
Learn More
Structural heart disease

bRight: Impact and Safety of the TriClip Device in a Real-World Cohort

The clinical importance of severe tricuspid regurgitation (TR) has been underestimated for many years now. However, studies...
solaci -
Learn More
Structural heart disease

SCOPE I Results at 3 Years: ACURATE Neo vs. SAPIEN 3

Transcatheter aortic valve implantation (TAVI) has become the standard treatment for elderly patients with severe symptomatic aortic...
solaci -
Learn More
Acute coronary syndromes

Mitral Valve Edge to Edge Repair for Papillary Muscle Rupture after Acute Myocardial Infarction

With an approximate incidence of 0.05% to 0.25%, post-acute myocardial infarction (AMI) mitral valve failure caused by...
solaci -
Learn More
Chronic Coronary Syndromes

What Is the Prognosis of an Acute Myocardial Infarction in the Presence of Moderate Aortic Stenosis?

Aortic stenosis (AS) is a common condition that shares risk factors with coronary artery disease. Many patients...
solaci -
Learn More
Structural heart disease

TAVR Durability at 5 Years in Intermediate Risk Patients

TAVR has been shown beneficial in patients across the risk spectrum. The PARTNER 2 SAPIEN 3 (P2S3i)...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

ROUTE TRAIL: DKCRUSH vs. DKRUSH Culotte in Non-Left Main Bifurcation Lesions

Dr. Carlos Fava - 0
Coronary bifurcation lesions represent a frequent technical challenge, making between 15% and 20% of cases. Though provisional stenting is mostly used, complex bifurcations are...

TENDERA: Comparing Conventional vs. Distal Transradial Occlusion for Coronary Interventions

Dr. Omar Tupayachi - 0
Supported by robust data, favorably compared against the transfemoral, the transradial approach has consolidated as the safest method for percutaneous intervention, particularly in terms...

Asymptomatic Aortic Stenosis: A Complex Decision

Dr. Carlos Fava - 0
Asymptomatic severe aortic stenosis continues to pose a significant challenge when it comes to clinical decision-making, often due to the difficulty in identifying symptoms....

Institutional News

Hemodynamics and Interventional Cardioangiology Hybrid Training Course SOLACI-CACI

solaci - 0
We are now open for registration to the hybrid training course on Hemodynamics and Interventional Cardioangiology for Technicians and Nurses SOLACI-CACI 2025 Find all course...

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy